Variable Impact of CD39 in Experimental Murine Colitis-Reference-Cited by-同舟云学术

Variable Impact of CD39 in Experimental Murine Colitis

Published:2010-10-09 Issue:5 Volume:56 Page:1393-1403
ISSN:0163-2116
Container-title:Digestive Diseases and Sciences
language:en
Short-container-title:Dig Dis Sci

Author:

Künzli Beat M.,Berberat Pascal O.,Dwyer Karen,Deaglio Silvia,Csizmadia Eva,Cowan Peter,d’Apice Anthony,Moore Gregory,Enjyoji Keiichi,Friess Helmut,Robson Simon C.

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology,Physiology

Link

http://link.springer.com/content/pdf/10.1007/s10620-010-1425-9.pdf

Reference34 articles.

1. Heller F, Fuss IJ, Nieuwenhuis EE, Blumberg RS, Strober W. Oxazolone colitis, a Th2 colitis model resembling ulcerative colitis, is mediated by IL-13-producing NK-T cells. Immunity. 2002;17:629–638.

2. Fiocchi C. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology. 1998;115:182–205.

3. Loftus EV Jr. Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology. 2004;126:1504–1517.

4. Apte MV, Haber PS, Darby SJ, et al. Pancreatic stellate cells are activated by proinflammatory cytokines: implications for pancreatic fibrogenesis. Gut. 1999;44:534–541.

5. Buell G, Lewis C, Collo G, North RA, Surprenant A. An antagonist-insensitive P2X receptor expressed in epithelia and brain. Embo J. 1996;15:55–62.

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hypoxic Functional Regulation Pathways in the GI Tract: Focus on the HIF-1α and Microbiota’s Crosstalk;Inflammatory Bowel Diseases;2024-03-14

2. Targeting ectonucleotidases to treat inflammation and halt cancer development in the gut;Biochemical Pharmacology;2021-05

3. Ectonucleotidase Modulation of Lymphocyte Function in Gut and Liver;Frontiers in Cell and Developmental Biology;2021-01-21

4. CD39/CD73/A2a Adenosine Metabolic Pathway: Targets for Moxibustion in Treating DSS-Induced Ulcerative Colitis;The American Journal of Chinese Medicine;2021-01

5. Implications of CD39 in immune-related diseases;International Immunopharmacology;2020-12